Overview

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Status:
Completed
Trial end date:
2020-07-27
Target enrollment:
Participant gender:
Summary
This study is conducted to evaluate the seizure-free rate of the 26-week Maintenance Period in untreated participants with partial onset seizures (POS).
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Co., Ltd.